Bioorthogonal Decaging Reactions for Targeted Drug Activation

Area of Science:

• Chemical Biology
• Medicinal Chemistry
• Drug Delivery

Background:

• Bioorthogonal decaging reactions offer precise control over molecular transformations.
• These reactions are biocompatible and can be performed within living systems without disrupting endogenous processes.
• Applications include controlled activation of proteins, release of fluorophores, and targeted drug delivery.

Purpose of the Study:

• To review the application of bioorthogonal decaging reactions for targeted drug activation, particularly prodrugs and antibody-drug conjugates (ADCs).
• To emphasize the development of bifunctional linkers for studying bioorthogonal chemistry in ADC activation.

Main Methods:

• Focus on bioorthogonal decaging strategies for selective drug activation.
• Discussion of tissue-selective activation of prodrugs and ADCs.
• Exploration of bifunctional linkers for bioorthogonal chemistry in ADC activation.

Main Results:

• Bioorthogonal decaging provides a highly selective and controllable method for activating prodrugs and ADCs.
• This approach reduces toxicity associated with off-target drug release.
• Development of bifunctional linkers facilitates studies in this area.

Conclusions:

• Bioorthogonal decaging is a powerful tool for targeted drug activation in vivo.
• It offers a significant advantage over endogenous activation strategies by minimizing systemic toxicity.
• Further development of bifunctional linkers will advance the use of bioorthogonal chemistry in ADC-based therapeutics.